Ewing's sarcoma overview: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:
==Overview==
==Overview==
'''Ewing's sarcoma''' is the common name for ''[[primitive neuroectodermal tumor]]''. It is a rare disease, and until recently, it had a very low long term survival rate.  It is a small round-cell [[tumor]] in which [[cancer]] cells are found in the [[bone]] or in soft [[biological tissue|tissue]] (rarer). The most common areas in which it occurs are the [[pelvis]], the [[femur]], the [[humerus]], and the [[ribs]]. [[James Ewing]] (1866-1943) first described the tumor, establishing that the disease was separate from [[lymphoma]] and other types of cancer known at that time. Ewing's sarcoma occurs most frequently in male teenagers.
'''Ewing's sarcoma''' is the common name for ''[[primitive neuroectodermal tumor]]''. It is a rare disease, and until recently, it had a very low long term survival rate.  It is a small round-cell [[tumor]] in which [[cancer]] cells are found in the [[bone]] or in soft [[biological tissue|tissue]] (rarer). The most common areas in which it occurs are the [[pelvis]], the [[femur]], the [[humerus]], and the [[ribs]]. [[James Ewing]] (1866-1943) first described the tumor, establishing that the disease was separate from [[lymphoma]] and other types of cancer known at that time. Ewing's sarcoma occurs most frequently in male teenagers.
A more famous case of Ewing's sarcoma occurred at Boston College in Chestnut Hill, Massachusetts. A football player for BC, named Mark Herzlich, was diagnosed with Ewing's sarcoma in 2009. With help from new treatments and surgery, he was able to beat the cancer. He currently plays in the NFL for the New York Giants.


==References==
==References==

Revision as of 16:12, 21 December 2011

Ewing's sarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ewing's sarcoma from other diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ewing's sarcoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ewing's sarcoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ewing's sarcoma overview

CDC on Ewing's sarcoma overview

Ewing's sarcoma overview in the news

Blogs on Ewing's sarcoma overview

Directions to Hospitals Treating Ewing's sarcoma

Risk calculators and risk factors for Ewing's sarcoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-In-Chief: Michael Maddaleni, B.S.

Overview

Ewing's sarcoma is the common name for primitive neuroectodermal tumor. It is a rare disease, and until recently, it had a very low long term survival rate. It is a small round-cell tumor in which cancer cells are found in the bone or in soft tissue (rarer). The most common areas in which it occurs are the pelvis, the femur, the humerus, and the ribs. James Ewing (1866-1943) first described the tumor, establishing that the disease was separate from lymphoma and other types of cancer known at that time. Ewing's sarcoma occurs most frequently in male teenagers.

A more famous case of Ewing's sarcoma occurred at Boston College in Chestnut Hill, Massachusetts. A football player for BC, named Mark Herzlich, was diagnosed with Ewing's sarcoma in 2009. With help from new treatments and surgery, he was able to beat the cancer. He currently plays in the NFL for the New York Giants.

References

Template:WH Template:WS